Abstract lar matrix components. Glycoxidative modification may have a functional link to AA amyloid deposition Background. Ne-carboxymethyllysine (CML) is a product of the oxidative modification of glycated proteins, in renal tissues. which damages proteins with ageing, diabetes, uraemia and Alzheimer's disease. In contrast, pyrraline is one Keywords: AA amyloid; CML; extracellular matrix; of the advanced glycation end products, which is glycoxidative modification; kidney independent of oxidative processes. CML has been identified in b-amyloid of Alzheimer's disease and b 2 -microglobulin-associated amyloid. We investigated whether CML and pyrraline are formed in AA and Introduction AL amyloid of the kidney. Method. Renal specimens from 19 cases of AA amyl-During the normal ageing process, body proteins are oidosis and 14 cases of AL amyloidosis were investi-progressively and irreversibly modified with advanced gated for immunolocalization of CML, pyrraline, glycation end products (AGEs) [1] . AGEs may procollagen type IV and laminin in amyloid deposits. duce adverse effects on tissues and cells via a variety Renal biopsies of 10 age-matched cases with thin of mechanisms involving the alteration of tissue protein basement membrane disease and normal renal function structure and function [2, 3] . Furthermore, the progreswere used as controls. The fractional areas of amyloid, sion of several diseases, including diabetes and athero-CML, laminin and collagen IV in glomeruli and inter-sclerosis, is influenced by AGE formation [1, 4] . AGEs stitium (%amyloid, %CML, %laminin and %collagen, have been identified immunohistochemically in amylrespectively) were calculated using the point counting oid proteins of senile plaques in patients with method. The correlation between these parameters was Alzheimer's disease and in elderly individuals [5] and evaluated using Spearman's rank correlation test. also in amyloid fibrils of damaged synovial tissues Results. CML colocalized with AA amyloid, but not from patients with haemodialysis-related amyloidosis AL amyloid, except in two cases of the latter with a [6 ] . Although AGEs might form in AA and AL long history of nephropathy exceeding 14 years. In amyloid proteins, their formation has not been fully contrast, pyrraline was not observed in either type of investigated [7] . amyloid. Mean %CML in AA amyloid was signifi-AGE formation commences with a chemical reaction cantly higher than %collagen and %laminin in glomer-between reducing sugars and amino acids, and after uli and interstitium, indicating that AA amyloid is subsequent reactions over time, a heterogeneous group modified by CML independent of colocalized extracel-of products, AGEs, are formed. The formation of a lular matrix. %CML significantly correlated with subgroup of AGEs, including Ne-carboxymethyllysine %amyloid both in glomeruli and interstitium in AA (CML) and pentosidine, requires both glycation and amyloidosis. AL amyloid cases with a long history of oxidation, and accordingly these are called 'glycoxidnephropathy showed positive staining for CML in ation products'. However, the formation of other glomeruli and interstitium but no staining for collagen AGEs, such as pyrraline and imidazolone, is independ-IV and laminin in amyloid deposits. ent of oxidation. Highly reactive carbonyl compounds Conclusion. CML modification may occur in amyloid and free oxygen radicals are produced during the deposits of AA amyloidosis, independent of extracellu-formation of glycoxidation products. These agents induce several biological effects [3] and have been
monoclonal antibody, 6D12 recognized CML as an epitope by AGE modification in AA and AL amyloidosis. To among AGE-structures [13] . To prepare monoclonal mouse clarify the modification of AGEs in AA and AL anti-pyrraline antibody, 6 mg of caproyl pyrraline, syntheamyloid proteins in relation to oxidative stress, we sized as described previously [12] , was conjugated with 6 mg investigated the formation of AGEs, including glycox-of human serum albumin (HSA). The conjugate was immunidation products, CML, and nonoxidative AGEs, pyr-ized in Balb/c mice and splenic lymphocytes were fused with raline, in amyloid deposits using renal tissues from myeloma P3U1 cells. The hybrid cells were screened and two amyloid patients.
cell lines positive for both caproyl pyrraline-HSA and caproyl Extracellular matrix proteins, including collagen pyrraline-conjugated with keyhole limpet haemocyanin type IV and laminin, are present in amyloid deposits ( KLH ), but negative for HSA, were selected through successive subcloning. On-line, termed H12, was produced from [10, 11] . AGE modification of collagen and other extraascitic fluid of Balb/c mice and futher purified by protein cellular matrix proteins has been reported previously G-affinity chromatography to IgG1. Immunochemical studies [1, 4, 8] . Here we also investigated a possible colocalizshowed that the reactivity of H12 to caproyl pyrralineation of collagen type IV and laminin in amyloid conjugated HAS was selectively inhibited by caproyl pyrradeposits to answer the question whether AGE forma-line, but not by caproic acid, indicating that the epitope of tion in amyloid is related to colocalized extracellular H12 was the pyrraline moiety. matrix proteins.
We applied morphometric analysis to immunohistoImmunohistochemistry chemically stained serial sections of the kidney and quantified the extent of modification by CML and the Paraffin-embedded samples were cut into 3-mm sections and area of colocalization of extracellular matrix in affected subjected to indirect immunohistochemical staining. The amyloid proteins. With this quantification, we were alkaline phosphatase and anti-alkaline phosphatase method able to compare the degree of involvement of CML (APAAP) was applied for anti-CML, pyrraline, amyloid A with that of extracellular matrix proteins in amyloid and b 2 -microglobulin (b 2 -M ) and labelled avidinedeposits.
streptavidine (LSAB) method for collagen type IV, laminin and heparan sulfate proteoglycan core protein (HSPG). The following primary antibodies were used, monoclonal mouse
Patients and methods
anti-CML (6D12, provided by Kumamoto University, Japan) [12] , mouse anti-pyrraline (H12, provided by Kumamoto University), mouse anti-amyloid AA protein
Patients
(Dako), mouse anti-HSPG (Chemicon International Inc., Temecula, CA, USA) antibodies and polyclonal rabbit antiRenal biopsy specimens were obtained from 33 cases of b 2 -M (Dako), mouse anti-collagen type IV (Shiseido Co. systemic amyloidosis, including 19 patients with AA amyl-Japan) and rabbit anti-laminin (LSL, USA) antibodies. oidosis and 13 patients and one autopsy case of AL amyl-Sections were subjected to the following protease pretreatoidosis. The clinical data from all subjects are summarized ment: 5 mg/dl of pronase (Dako) for 30 min at 37°C for in Tables 1 and 2 . In addition, we examined 10 age-matched CML, 0.5 mg/dl of pronase for 20 min at room temperature cases (age range 30-70 years, mean 59±10) with no renal for amyloid AA, 0.5 mg/dl of pronase for 30 min at 37°C disease and with normal renal function as the control group. for pyrraline, 2.5 mg/dl of pronase for 20 min at 37°C for b 2 -M, and 0.05 mg/dl of pronase for 10 min at room temper-
Routine staining methods
ature, followed by 1% pepsin for 90 min at 37°C for laminin, collagen type IV and HSPG. After treatment with 4% skim Samples were fixed in 10% buffered formalin and embedded milk for 20 min at room temperature, sections were incubated in paraffin. For light-microscopy, sections were stained with overnight with various primary antibodies (other than antihaematoxylin-eosin, periodic acid-Schiff, periodic acid-CML and anti-pyrraline antibodies) at 4°C. CML and pyrramethenamine-silver stain and Congo red with or without line were examined by incubation with anti-CML and antipretreatment with potassium permanganate ( KMnO 4 ). pyrraline antibodies overnight at room temperature, respectFrozen samples of AL amyloidosis cases were subjected to a ively. Each primary antibody was used at the following direct immunostaining method using antibody for l-and k-dilution: CML, 1:750; pyrraline, 1:500; AA amyloid, 1:100; light chain (Dako, Glostrup, Denmark). Amyloid deposits b 2 -M, 1:500; laminin, 1:2000; collagen type IV, 1:1000; and were determined by the positive green birefringence under HSPG, 1:25. After washing with phosphate-buffered saline polarized light in Congo red-stained sections. AA amyloid (PBS), sections were incubated with the secondary antibody protein was identified by positive staining with both Congo for 60 min at room temperature. The sections were then red and anti-AA amyloid antibody. However, AL amyloid incubated with alkaline phosphatase-conjugated streptavidprotein was determined by positive staining with Congo red, ine and monoclonal alkaline phosphatase-anti-alkaline phoswhich was resistant to KMnO 4 reaction and negative staining phatase complex (Dako) for 60 min at room temperature for with anti-AA amyloid antibody. Ten cases were subclassified LSAB and APAAP methods, respectively. All immunostained to A l-type and A k-type (n=8, 2, respectively) according sections were visualized by reaction with a solution of new to the positive staining of l-and k-light chain, respectively. fuchsin (naphthol AS-BI phosphate). Couterstaining was performed using Mayer's haematoxylin.
Preparation of anti-CML antibody and anti-pyrraline antibody Morphometry
To evaluate the degree of staining for various antigens in Preparation of anti-CML antibody (6D12) was as described previously [12] . A recent study from our group showed that each section, morphometric analysis was performed using Case 13, 14 aAutopsy case; bdata excluded case 14. Abbreviations: MM, multiple myeloma; NS, nephrotic syndrome; HT, hypertension; BUN, blood urea nitrogen; ND, not determined. Table 1 ). The glomerulus showed mesangial-nodular distribution of AA amyloid protein. Note the abundant and intense staining for CML in the AA-amyloid-positive area. CML was also found in the proximal tubular epithelium. In contrast, collagen type IV is faintly stained in AA amyloid positive area (arrow). A-C ×400.
the point counting method of Mackensen et al. [14] . The examiner was blinded to the clinical background. The section was examined using a 100-point grid placed in the 10× ocular of a light microscope. We selected several glomeruli observed in suitable aspect, such as those wihout obvious peripheral cut planes, global sclerosis and severe shrinkage, using 40× objective and randomly chose several fields with aAL amyloidosis with nephropathy of less than 4 years duration. bAL amyloidosis with nephropathy of more than 14 years duration. Volume fraction of amyloid positive area (%amyloid ) was calculated as (Pp/Pp+Pn)×100, where Pp is points falling on the stained area and Pn is that on non-stained area for each glomerulus and interstitium. The Pp for CML, laminin, and collagen type IV was counted at amyloid-positive site. The volume fractional area for CML, laminin and collagen type IV was calculated as the above mentioned formula. amyloid protein-positive interstitium, excluding large vessels, ium or in each subject using Spearman's rank correlation test. The correlation between %amyloid and various clinical using a 10× objective. Points falling on stained area (Pp) and points falling on non-stained area (Pn) were counted for parameters, including the duration of underlying disease, that of nephropathy, 1/serum creatinine and the degree of each glomerulus and interstitium. The area, which was immunohistochemically positive for AA amyloid protein, proteinuria, was also determined by Spearman's rank correlation test. Mann-Whitney's U-test was applied to evaluate was classified as the AA-amyloid positive area. In contrast, the Congo red-positive and AA-amyloid negative area was differences in %amyloid, %CML, %laminin and %collagen between AA and AL amyloidosis. A P-value of less than classified as the AL-amyloid positive area for AL amyloidosis. The volume fraction of amyloid-protein positive area 0.05 was taken as the level of significance. AA and AL amyloidosis. The average duration of the underlying disease in AA amyloidosis was longer than in AL amyloidosis (P<0.001). The duration of nephroStatistical analysis pathy, defined by urinary abnormalities or nephrotic syndrome, was not different between AA and AL
The correlation between %amyloid and %CML, %laminin and %collagen was examined in each glomerulus and interstit-amyloidosis. Nephrotic syndrome was observed less Table 2 ). (D-F ) were from a patient with primary AL amyloidosis associated with nephropathy for more than 14 years (case 13). The glomerulus of case 11 showed mesangial-capillary amyloid distribution and no staining for CML (A), pyrraline (B) or collagen type IV (C ). In contrast, the glomerulus of case 13 showed mesangial-nodular amyloid distribution. CML (D) was intensely distributed in Congo red positive areas, but pyrraline (E ) and collagen type IV (F ) were negative in amyloid protein. A-F ×400.
frequently in AA (47%) than in AL amyloidosis (85%). Two cases of primary AL amyloidosis (cases 13 and 14) had a longer duration of disease and nephropathy AA amyloidosis showed a higher incidence of renal dysfunction (49%) than AL amyloidosis (19%), which than other AL amyloid cases. Case 13 had had proteinuria for 18 years, but showed no other complicawas defined as blood urea nitrogen (BUN ) >30 mg/dl, serum creatinine >1.5 mg/dl or creatinine clearance tions. Case 14, the autopsy case, was diagnosed as primary AL amyloidosis with plasma cell dysclasia and <50 ml/min. nephrotic syndrome at age 63 years. She had undergone the mean relative %CML of AL amyloidosis in cases with a long history of nephropathy was similar to that haemodialysis for 14 years.
of AA amyloid patients, it was significantly lower in cases with nephropathy of <4 years than in AA Amyloid deposition amyloid patients. Pyrraline was not detected in any The morphological distribution of glomerular amyloid site of amyloid deposits in AA and AL amyloidosis. deposition was classified into four types, including Apart from areas with amyloid deposits, positive stainmesangial-nodular, mesangial-capillary, perimem-ing for CML was noted in the proximal tubular branous and hilar patterns, according to Shiiki et al. epithelium and sclerotic arteries in both AA and AL [15] . In AA amyloidosis, glomerular amyloid distribu-amyloidosis. In comparison, pyrraline was found in the interstitium and fibrous intima of arteries but not tion was more frequently of the mesangial nodular in the proximal tubular epithelium. pattern (13 cases, 72%), than mesangial-capillary (three For control cases, CML was positive in the epithecases, 17%) and hilar patterns (two cases, 10%). One lium of proximal tubules and intima of artery in all case of AA amyloidois had no glomeruli in the specicases. In contast, pyralline was negative in tubular men. However, in AL amyloidosis, mesangial-capillary epithelium but positive in interstitium and in fibrous distribution was more frequently observed (11 cases, intima. Neither CML nor pyrraline were detected in 79%) than mesangial nodular (two cases, 14%) and glomeruli. hilar patterns (one case, 7%). Two cases of AL amyloidosis with a long history of nephropathy showed a Extracellular matrix components in amyloid deposits mesangial nodular amyloid deposition pattern.
Laminin and collagen type IV were detected in some As shown in Table 3 , %amyloid in glomeruli was AA-amyloid positive glomerular areas ( Figure 1C , not different between AA and AL amyloidosis. arrow) and interstitium ( Figure 2D, arrow) . As shown However, AA amyloidosis showed a significantly in Table 3 , %laminin and %collagen of AA amyloidosis higher %amyloid in the interstitium than AL amylwere less than %CML in the glomeruli and interstitium. oidosis. The two cases of AL amyloidosis with long
The relative %laminin and %collagen were significantly history of nephropathy showed a significantly higher greater in the interstitium than in glomeruli, suggesting amyloid deposition per glomeruli and per interstitium that laminin and collagen type IV are probably more compared with other cases of AL amyloidosis (P= abundant in interstitial amyloid deposits than in glom-0.001, Table 3 , right).
eruli in AA amyloidosis. HSPG showed focal deposits within amyloid stained areas of the interstitium in AGE deposition some cases of AA amyloidosis. In contrast, laminin, collagen type IV and HSPG were scarcely seen in CML colocalized with AA amyloid proteins in glomeramyloid positive areas of glomeruli and interstitium in uli ( Figure 1A and B) and interstitium ( Figure 2A and all cases of AL amyloidosis ( Figure 3C and F, Tables B), while it was scarcely present in AL amyloid positive 3 and 4). areas ( Figure 3A ) except for the two cases with a long history of nephropathy ( Figure 3D ). As shown in Correlation between %amyloid, %CML, %laminin and Table 3 , the level of relative %CML was high in %collagen glomeruli and interstitium positive for AA amyloid protein, suggesting that a significant amount of AA In both glomeruli and interstitia of AA amyloidosis, %amyloid correlated significantly with %CML, %lami-amyloid protein may be modified by CML. Although nin and %collagen, as shown in Figures 4-6 . However, the correlation coefficient between %amyloid and with the degree of proteinuria, but the correlation was %CML was significantly higher in both glomeruli and not statistically significant ( Table 5 , r s =0.395, P=0.13 interstitium than that between %amyloid and %laminin and r s =0.407, P=0.118). or %collagen. Furthermore, %amyloid correlated significantly with %CML in the glomeruli and interstitia of the two cases of AL amyloidosis with a long history Discussion of nephropathy ( Figure 7 ).
Our study provided strong evidence for the presence Correlation between clinical parameters, %amyloid and of CML-modified amyloid protein in the renal tissues %CML of patients with AA amyloidosis. CML has been identified immunohistochemically in b-amyloid protein In both glomeruli and interstitium, there was no correlation between %amyloid or %CML and various of senile plaques in patients with Alzheimer's disease and in elderly individuals [5] . CML-modified b 2 -M clinical parameters, including duration of nephropathy, that of underlying disease and 1/serum creatinine. has been detected in amyloid fibril from damaged synovial tissue of patients with haemodialysis-related %Amyloid and %CML in glomeruli tended to correlate . 6 . Correlation between %amyloid and %collagen in glomeruli and interstitium (B) in patients with AL amyloidosis associated with (A) and interstitium (B) of AA amyloidosis. Positive correlation nephropathy for more than 14 years. Positive correlation was was observed between %amyloid and %collagen both in glomeruli observed between %amyloid and %CML both in glomeruli and and interstitium.
interstitium.
histochemical detection of CML in AA amyloid amyloidosis [6 ] . However, the formation of CML in AA and AL amyloid proteins has not been investigated deposits in renal tissue. Furthermore, pretreatment of renal tissue with this enzyme allowed the detection of fully. Previous studies using immunohistochemical analysis showed no staining of CML in renal tissues in CML in the proximal tubular epithelium and fibrous intima of arteries, a finding consistent with the results either experimental murine AA amyloidosis [7] or human autopsy material of AA and AL amyloidosis reported by Horie et al. [17] . Negative controls, using nonimmunized serum and PBS instead of the primary [16 ] . The different results of CML staining in AA amyloid deposits seem to be due to different methods antibody showed negative staining in the AA-amyloid positive area. These results suggest that the immunoused for the pretreatment of paraffin-embedded sections. In a series of preliminary studies, we obtained histochemical staining using this pretreatment with pronase is specific for CML. Tissue-deposited amyloid partial positive staining for CML in AA amyloid deposits in only a limited number of cases, using proteins are shown to be resistant to several proteases [18] . AGE formation is known to cause proteasesections pretreated with 100% formic acid. However, the technique used in the present study showed that resistant cross-linking of peptides [8, 9] . Thus, the use of high concentrations of pronase may be necessary to pretreatment with high concentrations of pronase (5 mg/ml ) for 30 min in 37°C was optimal for immuno-express CML epitope in deposited AA amyloid protein. Previous studies have shown immunohistochemical [6 ] . Since CML modification was found in AA amyloid deposits in renal tissue, agents such as carbonyl comstaining of CML in b-amyloid [5] and b 2 -M-associated amyloid proteins [6 ] . However, none of these studies pounds and free oxygen radicals might be involved in the irreversible deposition of amyloid protein and provided a quantitative analysis of the degree of CML formation in tissue-deposited amyloid proteins. Our tissue damage in patients with AA amyloidosis.
In this study, CML was not detected in AL amyloid study demonstrated that amyloid deposits positive for CML were present both in glomeruli and interstitium except in two cases with a history of nephropathy exceeding 14 years. Foss et al. [20] recently identified in all cases of AA amyloidosis. In addition, morphometric analysis indicated that~80% of AA-amyloid the amino acid sequence of the k-light chain extracted from Bence Jones proteins of urine and tissue-deposited positive areas exhibited colocalization of CML in the glomeruli and interstitium. A significant correlation light chain, and found that Asn20 was glycosylated in both proteins. This suggests that AGE modification was also observed between %CML and %amyloid in glomeruli and interstitium in AA amyloidosis. These may occur in AL amyloid proteins. The formation of AGE requires long-term incubation. In fact, only a findings suggest that the formation of CML in AA amyloid protein may have a functional link to depos-negligible amount of CML has been identified in b 2 -M-associated amyloid of the synovial tissue in patients ition of AA amyloidosis.
AGE formation starts with the reaction of amino who underwent haemodialysis for less than 6 years [16 ] . In the present study, the clinical course of patients acids, particularly the side chain of lysine, arginine and histidine, with reducing sugars. This process leads via with AA amyloidosis, who showed CML formation in amyloid deposits, was significantly longer than that of reversible Schiff 's base adducts to protein-bound Amadori products. Through subsequent rearrange-AL amyloidosis with no formation of CML (17±10 vs 0.9±1.0 years). In contrast, two cases of AL amylment, dehydration and oxidation, a heterogeneous group of products, AGEs, are formed over time. AGEs oidosis with nephropathy of >14 years showed CML formation in deposited AL amyloid. Thus, CML may are considered to be formed by a chemical reaction dependent or independent of oxidation [9,10]. CML is require long incubation to form in amyloid protein and can occur in AL amyloid protein after long-term produced by an oxidation-dependent pathway and is thus termed a glycoxidation product. In contrast, the incubation. Extracellular matrix, including collagen type IV and formation of pyrraline and imidazolone is independent on oxidation (nonoxidative AGEs). Both CML and laminin, has been shown in AA-amyloid positive areas [10, 11] . Our study demonstrated colocalization of colimidazolone [19] have been detected in b 2 -M-associated amyloid deposits. However, it is unclear whether lagen type IV and laminin in AA-amyloid positiveareas of glomeruli and interstitium. Moreover, there glucoxidative products and nonoxidative AGEs are formed in AA amyloid deposits. In our study, immuno-was a positive correlation between %collagen, %lami-nin and %amyloid in AA amyloidosis. These results histochemical analysis showed that CML, a glycoxidative product, was formed in amyloid deposits in all suggest a close link between extracellular matrix formation and AA amyloid deposition, a finding consistent cases of AA amyloidosis. However, pyrraline, one of the nonoxidative AGEs, was negative in these cases. with the results of two separate studies [10, 11] . Because these extracellular matrix proteins are known to be In contrast, in most cases of AL amyloidosis, AL amyloid deposits did not react with the antibody susceptible to nonenzymatic glycation [8] , CML-positive areas of AA amyloid deposits may result from against CML or with that against pyrraline. These results suggest that accumulation of AGEs in AA CML modification of matrix proteins. However, the mean values of %laminin and %collagen were lower amyloid is closely related to accelerated oxidation of glycated proteins (glycoxidation). Recent studies have than that of %CML in AA amyloidosis.
Immunohistochemistry showed the presence of CML focused on the formation of highly reactive carbonyl compounds and oxygen free radicals during the oxida-in amyloid deposits negative for collagen type IV and laminin in AA amyloidosis. Moreover, in two cases of tion pathway of AGE formation [8, 9] . These products may contribute to the destruction of bone and synov-AL amyloidosis with nephropathy of more than 14 years, AL amyloid deposits were positive for CML but ium in patients with in b 2 -M-associated amyloidosis and significance of 'carbonyl stress' in long term uremic comnegative for collagen type IV and laminin. Combined 
